Financial statements Elfa Pharm
Balance sheet data of ELFA PHARM
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 18 089 339,72 | 19 102 094,16 | 19 733 964,31 | 21 503 227,94 | 20 017 271,07 |
| A. Fixed assets | 9 345 978,43 | 9 108 030,63 | 8 775 658,78 | 8 263 931,11 | 8 137 934,39 |
| B. Current assets | 8 743 361,29 | 9 994 063,53 | 10 958 305,53 | 13 239 296,83 | 11 879 336,68 |
| C. Share capital contributions (basic funds) | - | - | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | 0,00 | 0,00 | 0,00 |
| Total liabilities | 18 089 339,72 | 19 102 094,16 | 19 733 964,31 | 21 503 227,94 | 20 017 271,07 |
| A. Equity | 5 348 080,78 | 5 700 539,33 | 5 785 759,27 | 3 788 734,89 | 3 976 428,34 |
| B. Liabilities and provisions for liabilities | 12 741 258,94 | 13 401 554,83 | 13 948 205,04 | 17 714 493,05 | 16 040 842,73 |
| I. Long-term liabilities | 5 808 564,21 | 6 345 842,06 | 5 435 105,36 | 5 526 638,23 | 1 390 990,00 |
| II. Short-term liabilities | 6 735 194,03 | 6 525 227,30 | 8 333 714,23 | 11 923 841,88 | 14 316 671,67 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.